BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 29550264)

  • 1. Insulin downregulates C3 gene expression in human HepG2 cells through activation of PPARγ.
    Shavva VS; Bogomolova AM; Efremov AM; Trofimov AN; Nikitin AA; Babina AV; Nekrasova EV; Dizhe EB; Oleinikova GN; Missyul BV; Orlov SV
    Eur J Cell Biol; 2018 Apr; 97(3):204-215. PubMed ID: 29550264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor α positively regulates complement C3 expression but inhibits tumor necrosis factor α-mediated activation of C3 gene in mammalian hepatic-derived cells.
    Mogilenko DA; Kudriavtsev IV; Shavva VS; Dizhe EB; Vilenskaya EG; Efremov AM; Perevozchikov AP; Orlov SV
    J Biol Chem; 2013 Jan; 288(3):1726-38. PubMed ID: 23168409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic nuclear factor 4α positively regulates complement C3 expression and does not interfere with TNFα-mediated stimulation of C3 expression in HepG2 cells.
    Shavva VS; Mogilenko DA; Dizhe EB; Oleinikova GN; Perevozchikov AP; Orlov SV
    Gene; 2013 Jul; 524(2):187-92. PubMed ID: 23628799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin alleviates hepatic insulin resistance via PPARγ-dependent AKT activation.
    Ge Z; Zhang P; Hong T; Tang S; Meng R; Bi Y; Zhu D
    Sci Rep; 2015 Dec; 5():17878. PubMed ID: 26643367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARγ Represses Apolipoprotein A-I Gene but Impedes TNFα-Mediated ApoA-I Downregulation in HepG2 Cells.
    Shavva VS; Mogilenko DA; Bogomolova AM; Nikitin AA; Dizhe EB; Efremov AM; Oleinikova GN; Perevozchikov AP; Orlov SV
    J Cell Biochem; 2016 Sep; 117(9):2010-22. PubMed ID: 26813964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARγ activates ABCA1 gene transcription but reduces the level of ABCA1 protein in HepG2 cells.
    Mogilenko DA; Shavva VS; Dizhe EB; Orlov SV; Perevozchikov AP
    Biochem Biophys Res Commun; 2010 Nov; 402(3):477-82. PubMed ID: 20951680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptors-α and -γ, and cAMP-mediated pathways, control retinol-binding protein-4 gene expression in brown adipose tissue.
    Rosell M; Hondares E; Iwamoto S; Gonzalez FJ; Wabitsch M; Staels B; Olmos Y; Monsalve M; Giralt M; Iglesias R; Villarroya F
    Endocrinology; 2012 Mar; 153(3):1162-73. PubMed ID: 22253419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2J2 attenuates metabolic dysfunction in diabetic mice by reducing hepatic inflammation via the PPARγ.
    Li R; Xu X; Chen C; Wang Y; Gruzdev A; Zeldin DC; Wang DW
    Am J Physiol Endocrinol Metab; 2015 Feb; 308(4):E270-82. PubMed ID: 25389363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric Acid Is Associated With Inflammatory Biomarkers and Induces Inflammation Via Activating the NF-κB Signaling Pathway in HepG2 Cells.
    Spiga R; Marini MA; Mancuso E; Di Fatta C; Fuoco A; Perticone F; Andreozzi F; Mannino GC; Sesti G
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1241-1249. PubMed ID: 28408375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel compound 4010B-30 upregulates apolipoprotein A-I gene expression through activation of PPARγ in HepG2 cells.
    Du Y; Wang L; Si S; Yang Y; Hong B
    Atherosclerosis; 2015 Apr; 239(2):589-98. PubMed ID: 25734982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the nuclear receptors HNF4 alpha, PPAR alpha, and LXRs in the TNF alpha-mediated inhibition of human apolipoprotein A-I gene expression in HepG2 cells.
    Mogilenko DA; Dizhe EB; Shavva VS; Lapikov IA; Orlov SV; Perevozchikov AP
    Biochemistry; 2009 Dec; 48(50):11950-60. PubMed ID: 19883121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt.
    Jia Y; Wu C; Kim J; Kim B; Lee SJ
    J Nutr Biochem; 2016 Feb; 28():9-18. PubMed ID: 26878778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase-type plasminogen activator downregulates paraoxonase 1 expression in hepatocytes by stimulating peroxisome proliferator-activated receptor-γ nuclear export.
    Khateeb J; Kiyan Y; Aviram M; Tkachuk S; Dumler I; Fuhrman B
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):449-58. PubMed ID: 22155455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified Si-Miao-San extract inhibits inflammatory response and modulates insulin sensitivity in hepatocytes through an IKKβ/IRS-1/Akt-dependent pathway.
    Liu K; Luo T; Zhang Z; Wang T; Kou J; Liu B; Huang F
    J Ethnopharmacol; 2011 Jul; 136(3):473-9. PubMed ID: 21296137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FAM3A is a target gene of peroxisome proliferator-activated receptor gamma.
    Zhou Y; Jia S; Wang C; Chen Z; Chi Y; Li J; Xu G; Guan Y; Yang J
    Biochim Biophys Acta; 2013 Aug; 1830(8):4160-70. PubMed ID: 23562554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum amyloid A activates peroxisome proliferator-activated receptor γ through extracellularly regulated kinase 1/2 and COX-2 expression in hepatocytes.
    Li H; Zhao Y; Zhou S; Heng CK
    Biochemistry; 2010 Nov; 49(44):9508-17. PubMed ID: 20853849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of JNK signaling pathway in lipopolysaccharide-induced complement C3 transcriptional activation from amphioxus Branchiostoma belcheri.
    Chen M; Wang C; Li Z; Chen J
    Fish Shellfish Immunol; 2019 Mar; 86():196-203. PubMed ID: 30458310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of IGFBP-2 expression during fasting.
    Kang HS; Kim MY; Kim SJ; Lee JH; Kim YD; Seo YK; Bae JH; Oh GT; Song DK; Ahn YH; Im SS
    Biochem J; 2015 May; 467(3):453-60. PubMed ID: 25695641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-carnitine ameliorates the liver inflammatory response by regulating carnitine palmitoyltransferase I-dependent PPARγ signaling.
    Jiang F; Zhang Z; Zhang Y; Wu J; Yu L; Liu S
    Mol Med Rep; 2016 Feb; 13(2):1320-8. PubMed ID: 26647854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.